Cargando…

Effects of Alirocumab on Triglyceride Metabolism: A Fat-Tolerance Test and Nuclear Magnetic Resonance Spectroscopy Study

Background: PCSK9 antibodies strongly reduce LDL cholesterol. The effects of PCSK9 antibodies on triglyceride metabolism are less pronounced. The present study aimed to investigate in detail the effects of alirocumab on triglycerides, triglyceride-rich lipoproteins, and lipase regulators. Methods: A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Metzner, Thomas, Leitner, Deborah R., Mellitzer, Karin, Beck, Andrea, Sourij, Harald, Stojakovic, Tatjana, Reishofer, Gernot, März, Winfried, Landmesser, Ulf, Scharnagl, Hubert, Toplak, Hermann, Silbernagel, Günther
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774139/ https://www.ncbi.nlm.nih.gov/pubmed/35052871 http://dx.doi.org/10.3390/biomedicines10010193

Ejemplares similares

Short-Term Treatment with Alirocumab, Flow-Dependent Dilatation of the Brachial Artery and Use of Magnetic Resonance Diffusion Tensor Imaging to Evaluate Vascular Structure: An Exploratory Pilot Study
por: Metzner, Thomas, et al.
Publicado: (2022)

Comparison of Two Nuclear Magnetic Resonance Spectroscopy Methods for the Measurement of Lipoprotein Particle Concentrations
por: Rief, Martin, et al.
Publicado: (2022)

Independent Effects of Kidney Function and Cholesterol Efflux on Cardiovascular Mortality
por: Ritsch, Andreas, et al.
Publicado: (2022)

Cholesterol Efflux Capacity and Cardiovascular Disease: The Ludwigshafen Risk and Cardiovascular Health (LURIC) Study
por: Ritsch, Andreas, et al.
Publicado: (2020)

Changes in Lipoprotein(a) Levels in People after ST Elevation Myocardial Infarction—The STEMI-Lipids Study
por: Sourij, Caren, et al.
Publicado: (2023)

Apolipoprotein CIII predicts cardiovascular events in patients with coronary artery disease: a prospective observational study
por: Katzmann, Julius L., et al.
Publicado: (2020)

Labordiagnostik von Fettstoffwechselstörungen
por: März, Winfried, et al.
Publicado: (2023)

Soluble urokinase plasminogen activation receptor and long-term outcomes in persons undergoing coronary angiography
por: Sommerer, Claudia, et al.
Publicado: (2019)

A low-fat spread with added plant sterols and fish omega-3 fatty acids lowers serum triglyceride and LDL-cholesterol concentrations in individuals with modest hypercholesterolaemia and hypertriglyceridaemia
por: Blom, Wendy A. M., et al.
Publicado: (2018)

Neutrophil gelatinase-associated lipocalin levels are U-shaped in the Ludwigshafen Risk and Cardiovascular Health (LURIC) study—Impact for mortality
por: Woitas, Rainer P., et al.
Publicado: (2017)

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: guidelines, clinical reality and health economic aspects
por: Toplak, Hermann, et al.
Publicado: (2016)

HDL cholesterol: reappraisal of its clinical relevance
por: März, Winfried, et al.
Publicado: (2017)

The LDL Apolipoprotein B-to-LDL Cholesterol Ratio: Association with Cardiovascular Mortality and a Biomarker of Small, Dense LDLs
por: Silbernagel, Günther, et al.
Publicado: (2022)

Effect of alirocumab on individuals with type 2 diabetes, high triglycerides, and low high-density lipoprotein cholesterol
por: Colhoun, Helen M., et al.
Publicado: (2020)

FXR controls CHOP expression in steatohepatitis
por: Fuchs, Claudia D., et al.
Publicado: (2017)

Triglyceride concentrations and non-high-density lipoprotein cholesterol goal attainment in the ODYSSEY phase 3 trials with alirocumab
por: Vallejo-Vaz, Antonio J, et al.
Publicado: (2020)

Hypoglycaemia leads to a delayed increase in platelet and coagulation activation markers in people with type 2 diabetes treated with metformin only: Results from a stepwise hypoglycaemic clamp study
por: Aberer, Felix, et al.
Publicado: (2019)

Ethanol Causes Protein Precipitation—New Safety Issues for Catheter Locking Techniques
por: Schilcher, Gernot, et al.
Publicado: (2013)

Serum Bile Acids in Repaired Tetralogy of Fallot: A Marker for Liver and Heart?
por: Grangl, Gernot, et al.
Publicado: (2015)

PCSK9 Plasma Concentrations Are Independent of GFR and Do Not Predict Cardiovascular Events in Patients with Decreased GFR
por: Rogacev, Kyrill S., et al.
Publicado: (2016)

Telomere length, vitamin B12 and mortality in persons undergoing coronary angiography: the Ludwigshafen risk and cardiovascular health study
por: Pusceddu, Irene, et al.
Publicado: (2019)

HDL subclasses and mortality in acute heart failure patients
por: Degoricija, Vesna, et al.
Publicado: (2019)

Comment on: Davidson et al. High-Dose Vitamin D Supplementation in People With Prediabetes and Hypovitaminosis D. Diabetes Care 2013;36:260–266
por: Tripolt, Norbert J., et al.
Publicado: (2013)

Effect of Alirocumab on Stroke in ODYSSEY OUTCOMES
por: Jukema, J. Wouter, et al.
Publicado: (2019)

Impact of Endothelial Lipase on Cholesterol Efflux Capacity of Serum and High-density Lipoprotein
por: Schilcher, Irene, et al.
Publicado: (2017)

Triglycerides and Open Angle Glaucoma – A Meta-analysis with meta-regression
por: Pertl, Laura, et al.
Publicado: (2017)

Simvastatin Efficiently Lowers Small LDL-IgG Immune Complex Levels: A Therapeutic Quality beyond the Lipid-Lowering Effect
por: Hörl, Gerd, et al.
Publicado: (2016)

RE: Praluent (Alirocumab)-Induced Renal Injury
por: Rosenson, Robert S., et al.
Publicado: (2017)

Mortality Benefit of Alirocumab: A Bayesian Perspective
por: Labos, Christopher, et al.
Publicado: (2019)

Effect of High-Flux Dialysis on Circulating FGF-23 Levels in End-Stage Renal Disease Patients: Results from a Randomized Trial
por: Schneider, Andreas, et al.
Publicado: (2015)

Serum bile acids in term and preterm neonates: A case–control study determining reference values and the influence of early-onset sepsis
por: Zöhrer, Evelyn, et al.
Publicado: (2016)

Anemia of Chronic Disease in Patients With Cardiovascular Disease
por: Lanser, Lukas, et al.
Publicado: (2021)

Short-term effects of high-dose oral vitamin D3 in critically ill vitamin D deficient patients: a randomized, double-blind, placebo-controlled pilot study
por: Amrein, Karin, et al.
Publicado: (2011)

Cardiac involvement in a cross‐sectional cohort of myotonic dystrophies and other skeletal myopathies
por: Schmid, Johannes, et al.
Publicado: (2020)

Alirocumab and Lipid Levels, Inflammatory Biomarkers, Metabolomics, and Safety in Patients Receiving Maintenance Dialysis: The ALIrocumab in DIALysis Study (A Phase 3 Trial to Evaluate the Efficacy and Safety of Biweekly Alirocumab in Patients on a Stable Dialysis Regimen)
por: East, Cara, et al.
Publicado: (2022)

Effect of alirocumab on cataracts in patients with acute coronary syndromes
por: Suc, Gaspard, et al.
Publicado: (2023)

Beta-trace Protein as a new non-invasive immunological Marker for Quinolinic Acid-induced impaired Blood-Brain Barrier Integrity
por: Baranyi, Andreas, et al.
Publicado: (2017)

Serum concentrations of free fatty acids are associated with 3-month mortality in acute heart failure patients
por: Degoricija, Vesna, et al.
Publicado: (2019)

Non-steroidal FXR agonist cilofexor improves cholestatic liver injury in the Mdr2(-/-) mouse model of sclerosing cholangitis
por: Fuchs, Claudia D., et al.
Publicado: (2023)

Subclinical inflammation, telomere shortening, homocysteine, vitamin B6, and mortality: the Ludwigshafen Risk and Cardiovascular Health Study
por: Pusceddu, Irene, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2lnm3hh9p75oohn86c4oc3tghf